Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Organon & Co. market cap for the quarter ending 2026-07-24 was $3.55B, a 35.90% increase year-over-year.
Organon & Co. market cap for the quarter ending 2026-06-30 was $3.56B, a 41.55% increase year-over-year.
Organon & Co. market cap for the quarter ending 2026-04-27 was $3.46B, a 8.97% increase year-over-year.
Organon & Co. market cap for the quarter ending 2026-03-31 was $1.57B, a 59.11% decline year-over-year.
Organon & Co. market cap for fiscal 2026 was $3.55B.
Organon & Co. market cap for fiscal 2025 was $1.87B, a 51.51% decline from fiscal 2024.
Organon & Co. market cap for fiscal 2024 was $3.85B, a 4.35% increase from fiscal 2023.
Organon & Co. market cap for fiscal 2023 was $3.69B, a 48.12% decline from fiscal 2022.